Description
TRIOSKIN 15 GM is a topical cream manufactured by Incepta Pharmaceuticals Ltd., combining three active ingredients: Betamethasone Dipropionate (0.05%), Clotrimazole (1%), and Gentamicin Sulfate (0.1%). Betamethasone is a potent corticosteroid that reduces inflammation, itching, and redness. Clotrimazole is an antifungal agent effective against various dermatophytes and yeasts, while Gentamicin is a broad-spectrum antibiotic that combats bacterial infections. This combination provides a synergistic effect, making Trioskin effective in treating inflammatory skin conditions complicated by fungal and/or bacterial infections.
Indications:
Trioskin is indicated for the treatment of corticosteroid-responsive dermatoses when complicated by infections caused by bacteria and fungi. It is also effective in the treatment of tinea pedis, tinea cruris, tinea corporis, acute and chronic eczema, contact dermatitis, seborrheic dermatitis, chronic simple lichen, intertrigo, exfoliative dermatitis, papular urticaria, psoriasis, pruritus vulvae, pruritus ani, dermatitis solaris, skin mycosis (athlete's foot, trichophytia), tinea versicolor, insect bites, and skin diseases complicated by secondary bacterial infections.
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpeg)
.jpg)
.jpeg)
.jpeg)
.jpeg)
.jpg)
 100 IU 3 ML.webp)
.png)
 400MG.jpg)
.webp)
.jpg)
.webp)
.webp)
Change Language